Company

BIOCEPT INC (0001044378)

Standardized SEC financial data for BIOCEPT INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001044378 · Services-Medical Laboratories.

Gross margin

-10.0%

Operating margin

-123.7%

Net margin

-124.1%

Revenue growth (YoY)

-57.8%

Return on equity

-362.2%

Free cash flow

-$14.1M

Current ratio

2.97×

EPS (diluted)

$-1.89

Ratios for fiscal year 2022, standardized from SEC filings.

Income statement

USD	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022
Revenue	—	$3.3M	$5.5M	$27.5M	$61.2M	$25.9M
Cost of revenue	—	—	$11.0M	$21.3M	$37.8M	$28.4M
Gross profit	—	—	-$5.4M	$6.1M

Balance sheet

USD	FY2019	FY2019	FY2019	FY2020	FY2021	FY2022
Inventory	—	—	$768K	$1.9M	$2.9M	$2.0M
Total current assets	—	—	$13.9M	$32.6M	$45.7M	$16.3M
Property, plant & equipment	—	—	$1.5M	$2.3M	$2.4M

Cash flow

USD	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022
Operating cash flow	—	-$22.4M	-$23.0M	-$19.8M	$3.7M	-$13.3M
Capital expenditures	$250K	$145K	$735K	$867K	$1.6M	$807K
Free cash flow	—	-$22.5M	-$23.8M	-$20.7M

Get 0001044378 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001044378/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001044378/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001044378 filings on SEC EDGAR →